These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 28146578)
1. AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis. Chen X; Lin J; Liu Y; Peng J; Cao Y; Su Z; Wang T; Cheng J; Hu D PLoS One; 2017; 12(2):e0171210. PubMed ID: 28146578 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis. Fan YH; Wu MJ; Jiang Y; Ye M; Lu SG; Wu L; Zhu XG Oncotarget; 2017 Mar; 8(13):21410-21417. PubMed ID: 28199963 [TBL] [Abstract][Full Text] [Related]
3. The Significance of Long Non-coding RNA HULC in Predicting Prognosis and Metastasis of Cancers: a Meta-Analysis. Ding Y; Sun C; Li J; Hu L; Li M; Liu J; Pu L; Xiong S Pathol Oncol Res; 2019 Jan; 25(1):311-318. PubMed ID: 29110261 [TBL] [Abstract][Full Text] [Related]
4. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis. Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877 [TBL] [Abstract][Full Text] [Related]
5. High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer. Fang J; Qiao F; Tu J; Xu J; Ding F; Liu Y; Akuo BA; Hu J; Shao S Oncotarget; 2017 Jul; 8(28):45918-45927. PubMed ID: 28507281 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis. Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis. Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102 [No Abstract] [Full Text] [Related]
8. Long noncoding RNA GAS5 can predict metastasis and poor prognosis: a meta-analysis. Song W; Wang K; Zhang RJ; Dai QX; Zou SB Minerva Med; 2016 Feb; 107(1):70-6. PubMed ID: 26763654 [TBL] [Abstract][Full Text] [Related]
9. LncRNA PANDAR as a prognostic marker in Chinese cancer. Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211 [TBL] [Abstract][Full Text] [Related]
10. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis. Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HOTTIP as an independent prognostic marker in cancer. Fan Y; Yan T; Chai Y; Jiang Y; Zhu X Clin Chim Acta; 2018 Jul; 482():224-230. PubMed ID: 28778381 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis. Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704 [TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA TUG1 as a Potential Novel Biomarker for Predicting the Clinical Outcome of Cancer Patients: a Meta-Analysis. Li B; Shen S; Zhang W; Qi T; Hu Q; Cheng Y Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549987 [No Abstract] [Full Text] [Related]
14. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis. Li D; Wang R; Wu N; Yu Y Aging (Albany NY); 2022 Feb; 14(4):1797-1811. PubMed ID: 35183058 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis. Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912 [TBL] [Abstract][Full Text] [Related]
16. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis. Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241 [TBL] [Abstract][Full Text] [Related]
17. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis. Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271 [TBL] [Abstract][Full Text] [Related]
18. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis. Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis. Zhang G; Cai J J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis. Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]